EU QPPV/UK QPPV and local requirements: is this now a global role? Date: 21st April, 11.00-11.45 UK Sign up to join the webinar * indicates required Email Address * First Name
21 Nov, 2019
Click the link below to download and view the Essjay Solutions newsletter for October 2019
10 Jul, 2018
FDA Review of Previously-Rejected Arthritis Drug comes with conditions FDA is reconsidering approval for previously rejected arthritis drug by Eli Lilly and Incyte. However,
Are you prepared for the upcoming changeover to the new EU risk management plan (RMP) template? Seema Jaitly offers some timely guidance on the new EU RMP document. Click the
06 Feb, 2018
Top 5 healthcare industry predictions for the year 2018 In 2017, the healthcare industry saw several trends in healthcare technology advancement from FDA’s move to ease the
13 Nov, 2017
The e-cigarettes are now being brought under the purview of guideline and regulations by the Tobacco Products Directive 2014/14/EU (TPD), under the new rules for
13 Nov, 2017
On 22 November 2017, the European Medicines Agency (EMA) will launch a new and improved version of EudraVigilance, the European information system of suspected adverse
13 Nov, 2017
A welcome move by EMA on its first public hearing where Patients, carers, doctors, pharmacists and academia shared their experience and reviews on the usage of a medicine that
13 Nov, 2017
The European Medicines Agency (EMA) and the European Commission have updated the annex to the European Commission guideline on excipients in the labelling and package leaflet
EMA’s PRAC conducted a referral procedure to examine whether there is any evidence of a causal link between HPV vaccination and two syndromes, complex regional pain syndrome
Recent Posts
- EU QPPV/UK QPPV and local requirements: is this now a global role?
- Essjay Newsletter – October 2019
- Are your UK PV operations Brexit ready?
- New Approvals and Launches June
- Submitting Risk Management Plans on the New EU template: 3 tips
- How to Manage Compliant Reference Safety Information (RSI) and maintain compliance